Immunovaccine

(RHIP:APH)

By |

Profile

IMV Inc is a clinical-stage immuno-oncology company. The company is engaged in making immunotherapies more effective, more broadly applicable, and more widely available to people facing cancer and other serious diseases.

Contact Information

Website: www.imvaccine.com
Email: info@imvaccine.com
Main Phone: +1 902 492-1819
Address: 1344 Summer Street
Address 2: Suite 412
State: NS
City / Town: Halifax
Country: CAN
Postal Code: B3H 0A8

Issuer Information

Exchange: CDX
CEO: Frederic Ors
Employees: 33
NAICS: Pharmaceutical Preparation Manufacturing (325412)
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume 0 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 43,197,120.00 EPS (TTM) N/A PE Ratio N/A Exchange TSXV
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 2.5 2.5 2.5 2.5
Low Target Price Estimate 2.2 2.2 2.2 2.2
Mean Target Price Estimate 2.35 2.35 2.35 2.35
Standard Deviation 0.21 0.21 0.21 0.21
Date of Most Recent Estimate 09/20/17 09/20/17 09/20/17 09/20/17
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 1 1 1 0
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.65 1.65 1.65 2.3